Accelerating Time to Data in Cell and Gene Therapy Trials

April 28th, 2026
11 a.m. EDT

Cell and gene therapy (CGT) development relies on speed, yet scientific complexity and operational bottlenecks can delay the moment that matters most: access to meaningful data. In today’s high-cost, high-stakes environment, sponsors must generate early insights to inform critical go or no-go decisions, strengthen investor confidence, and sustain program momentum. 

In this webinar, our experts will explore the most common barriers slowing speed to data in CGT trials, including protocol complexity and amendments, site selection, patient identification and enrollment, manufacturing & logistics challenges, and data review processes. We will share actionable strategies to streamline study start-up, reduce operational friction, and improve coordination across stakeholders without compromising quality. 

Join us to gain practical insights that can help accelerate timelines, enhance trial execution, and bring you closer to the data that drives confident decision-making. 

Attendees will gain insights into: 

• Factors impacting speed to data in CGT trials 
• Key strategies and processes that can optimize study start-up activities 
• Accelerating CGT study timelines without compromising study quality or compliance 

Speakers:

Kenneth Ndugga-Kabuye, MD, FACMG – Vice President, Cell & Gene Therapy

Leslie Amos – Executive Director, Project Delivery, Cell & Gene Therapy